One stock that might be an intriguing choice for investors right now is ANI Pharmaceuticals, Inc. ANIP. This is because this security in the Medical-Biomedical/Genetics space is seeing solid earnings ...

The latest analyst update on ANI Pharmaceuticals centers on a modest shift in model fair value, moving from US$110.50 to US$110.63. Bullish and bearish analysts are using this small change to reframe ...

ANI Pharmaceuticals (ANIP) reported $247.06 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 29.6%. EPS of $2.33 for the same period compares to $1.63 ...

ANI Pharmaceuticals (ANIP) reported $211.37 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 53.1%. EPS of $1.80 for the same period compares to $1.02 a ...

One stock that might be an intriguing choice for investors right now is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) . This is because this security in the Medical-Biomedical/Genetics space is seeing solid ...